Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin

Japanese Journal of Cancer Research

Volumn 89, Issue 9, 1998, Pages 963-969

  Shishido, Takayuki ^a   Yasoshima, Takahiro ^a   Denno, Ryuichi ^a   Mukaiya, Mitsuhiro ^a   Sato, Noriyuki ^a   Hirata, Koichi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Cisplatin; Human pancreatic carcinoma; Metastasis; TNP 470

Indexed keywords

ANGIOGENESIS INHIBITOR; CISPLATIN; FUMAGILLOL CHLOROACETYLCARBAMATE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS CARCINOMA; PRIORITY JOURNAL; SPLEEN; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031766695     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00655.x     Document Type: Article

References (28)

1. Matsuno, S. and Sato, T. Surgical treatment for carcinoma of the pancreas. Experience in 272 patients. Am. J. Surg., 152, 499-504 (1986).
2. Health and Welfare Statistics Association. "Health and Welfare Statistics," Vol. 40 (1993).
3. Livingston, E. L., Welton, M. L. and Reber, H. A. Surgical treatment of pancreatic cancer: the United States experience. Int. J. Pancreatol., 9, 153-157 (1991).
4. Matsuno, S., Hisano, H., Kobari, M. and Akaishi, S. Growth-inhibitory effect of combination chemotherapy for human pancreatic cancer cell lines. Cancer, 66, 2369-2374 (1990).
5. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer, 59, 2006-2010 (1987).
6. Taylor, I. Should further studies of chemotherapy be carried out in pancreatic cancer? Eur. J. Cancer, 29, 1076-1078 (1993).
7. Folkman, J. Anti-angiogenesis: new concept for therapy of solid tumor. Ann. Surg., 175, 409-416 (1972).
8. Kusaka, M., Sudo, K., Fujita, T., Marui, S., Itou, F., Ingber, D. and Folkman, J. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem. Biophys. Res. Commun., 174, 1070-1076 (1991).
9. Yanase, T., Tamura, M., Fujita, K., Kodama, S. and Tanaka, K. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res., 53, 2566-2570 (1993).
10. Kusaka, M., Sudo, K., Matsutani, E., Kozai, Y., Marui, S., Fujita, T., Ingber, D. and Folkman, J. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Br. J. Cancer, 69, 212-216 (1994).
11. Yamamoto, T., Sudo, K. and Fujita, T. Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470). Anticancer Res., 14, 1-3 (1994).
12. Shishido, T., Yasoshima, T., Denno, R., Sato, N. and Hirata, K. Inhibition of liver metastasis of human gastric carcinoma by angiogenesis inhibitor TNP-470. Jpn. J. Cancer Res., 87, 958-962 (1996).
13. Yamaoka, M., Yamamoto, T., Masaki, T., Ikeyama, S., Sudo, K. and Fujita, T. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetylcarbamoyl)fumagillol (TNP-470; AGM-1470). Cancer Res., 53, 4262-4267 (1993).
14. Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H. and Folkman, J. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature, 348, 555-557 (1990).
15. Placidi, L., Cretton-Scott, E., Sousa, G., Rahmani, R., Placidi, M. and Sommadossi, J. P. Disposition and metabolism of the angiogenic moderator O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470) in human hepatocytes and tissue microsomes. Cancer Res., 55, 3036-3042 (1995).
16. Morikawa, K., Walker, S. M., Jessup, J. M. and Fidler, I. J. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res., 48, 1943-1948 (1988).
17. Sato, N., Sato, T., Takahashi, S. and Kikuchi, K. Establishment of murine endothelial cell lines that develop angiosarcomas in vivo: brief demonstration of a proposed animal model for Kaposi's sarcoma. Cancer Res., 46, 362-366 (1986).
18. Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minna, J. D. and Mitchell, J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay; assessment of chemosensitivity testing. Cancer Res., 47, 936-942 (1987).
19. Kato, T., Sato, K., Kakinuma, H. and Matsuda, Y. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470) and cytotoxic agents in mice. Cancer Res., 54, 5143-5147 (1994).
20. Yamaoka, M., Yamamoto, T., Ikeyama, S., Sudo, K. and Fujita, T. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res., 53, 5233-5236 (1993).
21. Tanaka, T., Konno, H., Matsuda, I., Nakamura, S. and Baba, S. Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470. Cancer Res., 55, 836-839 (1995).
22. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82, 4-6 (1990).
23. Mahadevan, V. and Hart, I. R. Metastasis and angiogenesis. Acta Oncol., 29, 97-103 (1990).
24. Figg, W. D., Pluda, J. M., Lush, R. M., Saville, M. W., Wyvill, K., Reed, E. and Yarchoan, R. The pharmacokinetics of TNP-470, a new angiogenesis inhibitor. Pharmacotherapy, 17, 91-97 (1997).
25. Oikawa, I., Hirata, K., Hata, F., Katsuramaki, T., Mukaiya, M. and Sasaki, K. Is adjuvant chemotherapy by continuous infusion 5-fluorouracil plus daily low dose cisplatin useful in advanced (stage IV) pancreatic cancer? Tumor Res., 32, 23-31 (1998).
26. Jeske, J., Hansen, R. M., Libnoch, J. A. and Anderson, T. 5-Fluorouracil infusion and low-dose weekly cisplatin: an analysis of increased toxicity. Am. J. Clin. Oncol. (CCT), 13, 485-488 (1990).
27. Toi, M., Yamamoto, Y., Imazawa, T., Takayanagi, T., Akutsu, K. and Tominaga, T. Antitumor effect of the angiogenesis inhibitor AGM-1470 and its combination effect with tamoxifen in DMBA induced mammary tumors in rats. Int. J. Oncol., 3, 525-528 (1993).
28. Teicher, B. A., Holden, S. A., Dupuis, N. P., Kakeji, Y., Ikebe, M., Emi, Y. and Goff, D. Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma. Breast Cancer Res. Treat., 36, 227-236 (1995).